[HTML][HTML] Hyperinsulinemia in obesity, inflammation, and cancer

AMY Zhang, EA Wellberg, JL Kopp… - … & metabolism journal, 2021 - synapse.koreamed.org
The relative insufficiency of insulin secretion and/or insulin action causes diabetes.
However, obesity and type 2 diabetes mellitus can be associated with an absolute increase …

Engineering islets from stem cells for advanced therapies of diabetes

J Siehler, AK Blöchinger, M Meier… - Nature reviews Drug …, 2021 - nature.com
Diabetes mellitus is a metabolic disorder that affects more than 460 million people
worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …

Stem cells applications in regenerative medicine and disease therapeutics

RS Mahla - International journal of cell biology, 2016 - Wiley Online Library
Regenerative medicine, the most recent and emerging branch of medical science, deals
with functional restoration of tissues or organs for the patient suffering from severe injuries or …

Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury

YT Song, PC Liu, J Tan, CY Zou, QJ Li, J Li-Ling… - Stem Cell Research & …, 2021 - Springer
Intrauterine adhesion refers to endometrial repair disorders which are usually caused by
uterine injury and may lead to a series of complications such as abnormal menstrual …

Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes

D An, A Chiu, JA Flanders, W Song… - Proceedings of the …, 2018 - National Acad Sciences
Cell encapsulation has been shown to hold promise for effective, long-term treatment of type
1 diabetes (T1D). However, challenges remain for its clinical applications. For example …

β-cell–mimetic designer cells provide closed-loop glycemic control

M Xie, H Ye, H Wang, G Charpin-El Hamri, C Lormeau… - Science, 2016 - science.org
Chronically deregulated blood-glucose concentrations in diabetes mellitus result from a loss
of pancreatic insulin-producing β cells (type 1 diabetes, T1D) or from impaired insulin …

A century-long journey from the discovery of insulin to the implantation of stem cell–derived islets

A Ramzy, PJ Belmonte, MJS Braam, S Ida… - Endocrine …, 2023 - academic.oup.com
For the past century, insulin injections have saved millions of lives, but glycemic instability is
still a persistent challenge for people with diabetes, leading to tremendous morbidity and …

Navigating two roads to glucose normalization in diabetes: automated insulin delivery devices and cell therapy

E Latres, DA Finan, JL Greenstein, A Kowalski… - Cell metabolism, 2019 - cell.com
Incredible strides have been made since the discovery of insulin almost 100 years ago.
Insulin formulations have improved dramatically, glucose levels can be measured …

focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute IsletCore

J Lyon, JE Manning Fox, AF Spigelman, R Kim… - …, 2016 - academic.oup.com
Recent years have seen an increased focus on human islet biology, and exciting findings in
the stem cell and genomic arenas highlight the need to define the key features of mature …

Autologous pluripotent stem cell–derived β-like cells for diabetes cellular therapy

JR Millman, FW Pagliuca - Diabetes, 2017 - Am Diabetes Assoc
Development of stem cell technologies for cell replacement therapy has progressed rapidly
in recent years. Diabetes has long been seen as one of the first applications for stem cell …